August 13 2021
Advocate Aurora Research Institute recently interviewed Ray Harrison, a United States Marine Corp veteran and family man, on his experiences through his journey with limited-stage small cell lung cancer (LS-SCLC). Ray offered readers a viewpoint of his journey from diagnosis through his current treatment on the National Cancer Institute-sponsored, NRG Oncology-led clinical trial, and the strength provided to him by his grandson Caynen.
The NRG-LU005 study that Ray is participating in evaluates whether doctors can lower the chance of LS-SCLC growing or spreading using the immunotherapy drug atezolizumab along with the standard chemotherapy and radiation therapy for this type of disease.
“If someone will eventually benefit from this, if I can help someone else, I won,” – Ray Harrison
The full interview can be found on pages 25-26 of the Advocate Aurora Research Institute 2020 Annual Report
Click here for the NRG-LU005 webpage with more information on this trial